Low-Dose Naltrexone Cost in New Hampshire (2026): Pricing, Insurance, and How to Save

What Low-Dose Naltrexone Actually Costs in New Hampshire

New Hampshire residents can expect to pay roughly $50 per month for compounded low-dose naltrexone filled at a licensed 503A compounding pharmacy. This price covers a 30-day supply of oral capsules, typically dosed between 1.5 mg and 4.5 mg taken once nightly.

That figure holds relatively steady across the state because LDN is not manufactured as a commercial product at low doses. The FDA approved naltrexone at 50 mg for opioid use disorder and alcohol dependence, but no pharmaceutical company markets a 1.5 mg to 4.5 mg tablet. Every LDN prescription must be individually compounded, which means the pricing is set by compounding pharmacies rather than by a manufacturer's wholesale acquisition cost. NH compounding pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act can legally prepare LDN with a valid patient-specific prescription.

The price can vary by $10 to $20 depending on the pharmacy, capsule count, and whether the prescription includes a custom titration schedule. Some providers start patients at 0.5 mg or 1 mg and increase by 0.5 mg increments every one to two weeks, which may require different capsule strengths during the first month. Ask the pharmacy upfront whether the titration supply carries extra charges. A few national compounding pharmacies that ship to New Hampshire offer prices in the $30 to $45 range, so comparing quotes is worth the five minutes it takes.

Why LDN Requires Compounding (and What That Means for NH Pricing)

Low-dose naltrexone sits in an unusual regulatory space. The drug itself has been FDA-approved since 1984, but only at the 50 mg strength for addiction medicine [1]. No company has pursued FDA approval for naltrexone at doses below 5 mg because the off-patent status of the molecule makes the economics of a new drug application unattractive. Running the phase III trials needed for a new indication could cost hundreds of millions of dollars with no patent exclusivity to recoup the investment.

This leaves compounding as the only legal pathway. New Hampshire permits 503A compounding pharmacies to prepare LDN capsules when a licensed prescriber writes a patient-specific prescription. The pharmacy must follow United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding, which governs potency, stability, and quality testing [2]. NH residents should verify that their pharmacy holds an active New Hampshire Board of Pharmacy license and compounds under 503A regulations.

The pricing consistency across New Hampshire reflects a simple economic reality: compounding LDN is straightforward. Naltrexone hydrochloride powder is inexpensive, the capsules require no specialized equipment beyond standard compounding tools, and the labor time per prescription is minimal. The $50 per month benchmark represents the pharmacy's compounding fee rather than any meaningful raw material cost.

Insurance Coverage for LDN in New Hampshire

Most commercial insurance plans in New Hampshire do not cover compounded medications, and LDN is no exception. Because LDN is an off-label use of naltrexone at a non-commercially available strength, insurers generally classify it as a non-formulary compounded product. This applies to plans offered through Anthem Blue Cross Blue Shield of New Hampshire, Harvard Pilgrim Health Care, Cigna, and Ambetter.

There are occasional exceptions. Some plans cover naltrexone 50 mg tablets, which a patient could theoretically split, but cutting a 50 mg tablet into a precise 4.5 mg dose is impractical and clinically inadvisable. A handful of employer-sponsored plans with broader compounding benefits may reimburse part of the cost if the prescriber submits documentation supporting medical necessity. The success rate for these appeals is low, but not zero.

Patients enrolled in plans through the New Hampshire Health Insurance Marketplace should check whether their specific plan has a compounding benefit. Call the pharmacy benefits number on the back of the insurance card and ask two direct questions: "Does my plan cover compounded medications?" and "Is there a prior authorization pathway for off-label naltrexone?"

According to the Endocrine Society's clinical practice guidelines, off-label drug coverage often requires a letter of medical necessity documenting failed trials of on-label alternatives [3]. Even when coverage is denied, the denial letter can sometimes be used to negotiate a lower cash price.

New Hampshire Medicaid and LDN

New Hampshire Medicaid does not cover low-dose naltrexone for off-label indications such as fibromyalgia, chronic pain, or autoimmune disease. The state's Medicaid program, NH Medicaid Care Management, restricts formulary coverage to FDA-approved indications unless a specific exception applies.

NH Medicaid does cover naltrexone at 50 mg for opioid use disorder under its substance use disorder benefit, and it covers the injectable formulation (Vivitrol) for the same indication. These coverages do not extend to compounded low-dose formulations.

Medicaid enrollees who want to try LDN have limited options. Paying out of pocket at $50 per month is the most direct route. Some compounding pharmacies offer sliding-scale pricing or monthly payment plans for patients who can demonstrate financial hardship. Asking the prescribing provider whether any patient assistance programs exist in the practice is another avenue worth exploring, though formal manufacturer assistance programs do not exist for compounded drugs the way they do for branded pharmaceuticals.

The Centers for Medicare & Medicaid Services (CMS) allows state Medicaid programs to cover off-label drugs if supported by certain compendia, but individual states must choose to exercise this option [4]. New Hampshire has not done so for LDN as of 2026.

Telehealth Access to LDN in New Hampshire

New Hampshire permits telehealth prescribing of low-dose naltrexone. Patients can consult with a licensed provider via video or audio visit, receive a prescription, and have it filled at any compounding pharmacy licensed to ship to New Hampshire. This is legal under the state's telehealth parity statute, which requires insurers to cover telehealth services on the same terms as in-person visits (though the compounded medication itself may still not be covered) [5].

Telehealth access matters for LDN because not every primary care physician is familiar with the drug at low doses. The published evidence base is growing but remains limited to small trials and observational studies. A pilot trial by Younger et al. (2009) enrolled 10 women with fibromyalgia and found that LDN at 4.5 mg per day reduced fibromyalgia symptoms by 30% compared to placebo, as measured by daily symptom diaries [6]. The trial was small but generated enough signal to prompt further research.

Dr. Jarred Younger, who led that pilot study at Stanford University, described the mechanism: "We believe LDN works by transiently blocking opioid receptors, which triggers an upregulation of endogenous opioid production and reduces microglial activation in the central nervous system" [6]. This proposed mechanism, centered on neuroinflammation rather than direct pain blockade, distinguishes LDN from conventional analgesics.

Several telehealth platforms now offer LDN consultations for New Hampshire residents. Costs for the telehealth visit itself range from $75 to $200 for an initial consultation, with follow-up visits typically $50 to $100. The visit cost is separate from the $50 per month medication cost. Some platforms bundle the consultation and first month of medication for $99 to $150.

The Evidence Behind Low-Dose Naltrexone

Prescribers in New Hampshire and elsewhere base LDN use on a growing but still early evidence base. The drug is not FDA-approved at low doses for any indication, which means every LDN prescription is off-label. Off-label prescribing is legal and common in medicine. Approximately 20% of all prescriptions written in the United States are for off-label indications, according to data published in the Journal of the American Medical Association [7].

The conditions most frequently treated with LDN include fibromyalgia, Crohn's disease, multiple sclerosis, complex regional pain syndrome, and certain autoimmune conditions. The evidence quality varies by condition.

For fibromyalgia, the Younger et al. pilot trial (2009, N=10) found a 30% reduction in symptoms [6]. A subsequent crossover trial by the same group (2013, N=31) confirmed these results, showing that LDN at 4.5 mg/day produced significant reductions in pain severity compared to placebo (P<0.05) [8]. Both trials were conducted at Stanford and published in peer-reviewed journals indexed on PubMed.

For Crohn's disease, Smith et al. (2007, N=17) found that 89% of patients showed clinical response and 67% achieved remission after 12 weeks of LDN at 4.5 mg nightly [9]. A follow-up randomized controlled trial by Smith et al. (2011, N=40) confirmed a significantly higher remission rate with LDN versus placebo (88% vs. 40%, P<0.001) [10].

For multiple sclerosis, a trial by Cree et al. (2010, N=80) found that LDN was well-tolerated and improved quality of life measures, though it did not significantly change neurological disability scores over eight weeks [11]. Longer trials are needed to assess disease-modifying potential.

The National Institutes of Health (NIH) currently lists multiple ongoing studies of LDN on ClinicalTrials.gov, suggesting that the evidence base will continue to expand over the next several years.

How to Get the Lowest Price on LDN in New Hampshire

Several strategies can reduce LDN costs below the standard $50 per month benchmark.

Compare compounding pharmacies. Prices vary between local NH compounding pharmacies and national mail-order compounders. Some national pharmacies licensed to ship to New Hampshire offer LDN at $30 to $40 per month. Verify that any out-of-state pharmacy holds the appropriate licenses.

Ask about 90-day supplies. Some compounding pharmacies discount the per-month cost when filling a 90-day supply, bringing the effective monthly cost to $35 to $45. Stability data for compounded LDN capsules typically supports a 90-day beyond-use date when stored at controlled room temperature per USP Chapter 795 guidelines [2].

Check for pharmacy discount programs. A small number of compounding pharmacies have introduced savings card programs or loyalty pricing for repeat prescriptions. These are pharmacy-specific, not manufacturer-backed, so ask directly. The savings typically amount to 10% to 15% off the cash price.

Use a telehealth platform with bundled pricing. Some telehealth services that specialize in LDN prescribing offer package pricing that includes the consultation, prescription management, and medication fulfillment. This can reduce total costs compared to paying separately for a provider visit and pharmacy fill.

Request generic naltrexone 50 mg with compounding instructions. In rare cases, a pharmacist can compound LDN from commercially available 50 mg tablets rather than from bulk powder. This approach is less common and may not meet USP standards depending on the pharmacy's protocols, so discuss it with the compounding pharmacist directly.

Side Effects and What New Hampshire Patients Should Know Before Starting

LDN is generally well-tolerated. The most common side effects reported in clinical trials include vivid dreams, mild headache, and transient nausea during the first one to two weeks of treatment. These effects typically resolve without intervention as the body adjusts to the medication [6] [8].

Because naltrexone is an opioid receptor antagonist, patients taking any opioid medication (including opioid-containing cough suppressants and certain antidiarrheal drugs like loperamide at high doses) should not take LDN without close medical supervision. Taking LDN while opioids are present in the body can precipitate acute opioid withdrawal, which is medically dangerous. The standard recommendation is a minimum 7-to-14-day opioid-free washout period before starting LDN, depending on the half-life of the specific opioid used [1].

New Hampshire prescribers should also be aware that LDN may interact with immunosuppressive medications used after organ transplantation. The immunomodulatory effects of LDN, while potentially beneficial in autoimmune disease, are contraindicated in patients who require pharmacological immunosuppression to prevent graft rejection.

Patients with hepatic impairment should have liver function tests checked before starting LDN. The FDA label for naltrexone 50 mg carries a boxed warning about hepatotoxicity at high doses (300 mg/day in early obesity trials), though this risk has not been demonstrated at the 1.5 to 4.5 mg doses used in LDN protocols [1]. Periodic liver function monitoring remains a reasonable precaution.

503A Compounding Regulations in New Hampshire

New Hampshire regulates compounding pharmacies through the New Hampshire Board of Pharmacy. Pharmacies operating under 503A must compound LDN only in response to a valid, patient-specific prescription from a licensed prescriber. They cannot compound naltrexone in anticipation of receiving prescriptions (sometimes called "batch compounding for stock") unless specific conditions are met.

The distinction between 503A and 503B facilities matters. Section 503A pharmacies are traditional compounding pharmacies that prepare medications for individual patients. Section 503B facilities are outsourcing facilities registered with the FDA that can compound larger batches without patient-specific prescriptions. Both types can legally prepare LDN, but 503B facilities are subject to FDA inspection under current Good Manufacturing Practice (cGMP) standards, which may offer an additional layer of quality assurance.

New Hampshire residents filling prescriptions at out-of-state compounding pharmacies should confirm that the pharmacy is licensed in both its home state and New Hampshire. The FDA's compounding page provides background on the regulatory framework [12].

As of 2026, the FDA's ongoing rulemaking around compounding has not restricted LDN preparation at 503A pharmacies, and no state-level restrictions in New Hampshire limit the compounding of naltrexone at low doses. A standard LDN prescription in New Hampshire reads: naltrexone 1.5 mg (or 3 mg, or 4.5 mg) capsule, take one capsule by mouth at bedtime, quantity 30, with refills as clinically indicated.